| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5b0785d2c8c18ff91a6915a05868f5b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e93484dfe3013b366bd821ac56f39b00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567defebca2fa3531a89cd1ba1783efd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4746
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
2005-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87db0a2d7dabc1c4f2cd1b91f799b1e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a1a41b4511cf40c507b0b1b909ee1b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac1034d034a0fe54d012d16297121cb8 |
| publicationDate |
2008-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008292592-A1 |
| titleOfInvention |
Oncolytic Adenovirus Armed with Therapeutic Genes |
| abstract |
The present invention involves compositions and methods for treating preventing cancer using compositions including replication competent adenovirus. The application competent adenovirus may or may not encode a therapeutic polynucleotide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019523008-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010272686-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021024207-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3490574-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11155622-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112126631-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8450106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11439678-B2 |
| priorityDate |
2004-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |